Info

2 Docs Talk: The podcast about healthcare, the science of medicine and everything in between.

Welcome to 2 Docs Talk. Join cohosts Kendall Britt, MD and Amy Rogers, MD for a 15 minute check-up on current issues in health, healthcare policy, and evidence- based medicine.
RSS Feed Subscribe in Apple Podcasts
2 Docs Talk: The podcast about healthcare, the science of medicine and everything in between.
2018
November
October
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May
April
March
February
January


2015
December


Categories

All Episodes
Archives
Categories
Now displaying: Category: healthcare policy
Nov 6, 2018

Kratom doesn't sound like your typical herbal supplement, but it does come with all the issues common to the supplement industry. Namely, it hasn't withstood the test of clinical trials to demonstrate safety and efficacy. 

And that causes problems. 

Problems like not knowing how much of the ingredient is in the supplement, or how much of other ingredients for that matter. Or wht kind of side effects might be evident if it were subjected to randomized placebo-controlled trials. 

But another problem is that it might actually offer a solution to a very big problem—opioid addiction But we don't know if it does because guess what? It hasn't been studied. 

This week, 2 Docs Talk about Kratom and why the regulatory requirements (or absence thereof) on the supplement industry might be causing us to miss out on some real benefits.

Mar 19, 2018

If you've had many conversations about healthcare reform, it is likely you've heard some variation on this theme: 

"Hospitals have to provide care for people who show up. So everyone can get healthcare when they need it. So when people say that can't get healthcare, that isn't true."

Is there any merit to that argument? Spoiler: NO. But if you want to hear more about where that idea comes from, take a listen. 

Resources:

https://www.cms.gov/Regulations-and-Guidance/Legislation/EMTALA/

http://www.kff.org/medicaid/state-indicator/medicaid-income-eligibility-limits-for-parents/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Mar 5, 2018

Right to Try laws have come about as a response to cumbersome paperwork required to access the FDA's compassionate use program. However, the FDA has lessened the paperwork required for terminally ill patients to access investigational drugs. 

So is Right to Try a meaningful movement, or is it simply one piece of an overaraching ideology.

Today, 2 Docs Talk about Right to Try laws and who they help.

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Jan 8, 2018

If you’ve paid any attention to the news over the past year or so, you’ve likely seen stories of greedy capitalists gouging the vulnerable by hiking up the prices of their life-saving drugs.

But are the prices hikes all that bad?

Yes. Yes, they are. And we talk about that to day on 2 Docs Talk.

Resources:

JAMA on Drug Pricing

Our episode on Hep C

Our episode on Alzheimers

Our episode on Pricing Transparency

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Jan 1, 2018

If you’ve paid any attention to the news over the past year or so, you’ve likely seen stories of greedy capitalists gouging the vulnerable by hiking up the prices of their life-saving drugs.

But are the prices hikes all that bad?

Yes. Yes, they are. And we talk about that to day on 2 Docs Talk.

Resources:

JAMA on Drug Pricing

Our episode on Hep C

Our episode on Alzheimers

Our episode on Pricing Transparency

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Dec 18, 2017

If you’ve ever tried to figure out the price of a medical procedure, you know it’s not that easy. In fact, research shows that complete pricing for medical procedures is unavailable when requested over one-third of the time.

As healthcare deductibles rise and indidviduals are affected more and directly by these costs, the issue of pricing transparency is growing. In this episode we talk about the problem posed by opaque medical pricing practices. We also dig into two innovative practice models that solve this transparency problem, as well as a few other issues in the delivery of healthcare and medicine.

Resources:

Surgery Center of Oklahoma

Turntable Health

Iora Health

JAMA: Availability of Consumer Prices from US Hospitals for a Common Surgical Procedure

 

Listen on iTunes

Listen on Libsyn

Oct 23, 2017

Physician burnout is a big issue in the medical community. According the the Medscape Lifestyle Report 2017, over half of physicians report burnout. But physician burnout isn’t just a problem for physicians. It is a problem for patients, for other medical staff, and for the health care economy.

Today we dig into the causes of physician burnout and how it can be addressed. Here’s a hint: It doesn’t involve meditation or counseling.

Resources:

Medscape Lifestyle Report 2017

2 Docs Talk About Pricing Transparency

2 Docs Talk About Medicare for All

2 Docs Talk About Drug Pricing

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Oct 16, 2017

If you watch any tv at all, it’s likely you’ve seen a drug ad. These ads generally show seemingly healthy people living normal lives, the message being the drug did this for them.

But are the drug ads telling the whole story? And should they even be advertising directly to consumers to begin with? We discuss this issue on today’s episode.

 

Resources:

Nivolumab Research from New England Journal of Medicine

What the FDA has to say about drug ads

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Aug 28, 2017

Medicaid is the subject of a lot of talk in today's political environment. Sadly much of what is said isn't based in fact, or it focuses on parts of the program that represent a tiny portion of its cost. 

Today, 2 Docs Talk about Medicaid, who it serves, and how it was affected (or, rather, supposed to be affected) by the Affordable Care Act.

Aug 7, 2017

If you've had many conversations about healthcare reform, it is likely you've heard some variation on this theme: 

"Hospitals have to provide care for people who show up. So everyone can get healthcare when they need it. So when people say that can't get healthcare, that isn't true."

Is there any merit to that argument? Spoiler: NO. But if you want to hear more about where that idea comes from, take a listen. 

Resources:

https://www.cms.gov/Regulations-and-Guidance/Legislation/EMTALA/

http://www.kff.org/medicaid/state-indicator/medicaid-income-eligibility-limits-for-parents/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Apr 3, 2017

Kendall and Amy are in agreement that hospice care is an important, compassionate aspect of healthcare that humanizes what can be a very clinical, impersonal process. We've both experience with hospice - personally and professionally. 

Sadly, like most aspects of healthcare, the potential for profit has introduced some ugly practices into what should be focused solely on the needs of dying patients and their families.

Today, Kendall and Amy talk about the good and the bad of hospice as it exists in 2017.

Resources:

 

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Mar 27, 2017

Ever since Sarah Palin famously accused Obamacare of promoting death panels, the idea remains a fixture for some politicians to fall back on to impugn the healhcare law. 

But were death panels ever a part of the original healthcare law? And more importantly, how should patients and their physicians be approaching the topic of death, if at all?

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Mar 20, 2017

In this follow up episode to last week, we dig in to how the American Healthcare Act, aka Trumpcare, will affect Medicaid, and who will benefit from all the tax breaks. 

We recorded this episode before the Congressional Budget Office came out with their evaluation of the plan. We weren't too far off, if anything we may have been generous with Trumpcare. We've linked the CBO report in the resources below in case you want to check it out for yourself.

Also, I mistakenly credited the Vox article to Ezra Klein, but it was Sarah Kliff who wrote the excellent summary of the AHCA. It's also linked below.

Resources:

Health Affairs Blog on AHCA

Kaiser’s side-by-side comparison of Obamacare and AHCA

Obamacare Essential Healht Benefits

Vox Article by Sarah Kliff

Summary of Congressional Budget Office Report

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Mar 13, 2017

UPDATE: Since the episode aired (like the very next day) the Congressional Budget Office came out with their assessment of the American Healthcare Act. It was not positive. Stay tuned to the second part of this episode coming out on Monday, March 20, where we will discuss what they had to say.

_________________

Over the past week, we've finally gotten to take a look at the elusive Republican healthcare plan, the proposed replacement for Obamacare.

In this episode we talk about the faults opponent found with Obamacare, and how the proposed plan, which we call Trumpcare, attempts to address those issues.

This is the first installment of a two-part episode on Trumpcare, so be sure to listen this week and next week to get our full analysis.

Resources:

Health Affairs Blog on AHCA

Kaiser's side-by-side comparison of Obamacare and AHCA

Obamacare Essential Healht Benefits

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Feb 20, 2017

Physician burnout is a big issue in the medical community. According the the Medscape Lifestyle Report 2017, over half of physicians report burnout. But physician burnout isn't just a problem for physicians. It is a problem for patients, for other medical staff, and for the health care economy. 

Today we dig into the causes of physician burnout and how it can be addressed. Here's a hint: It doesn't involve meditation or counseling.

Resources:

Medscape Lifestyle Report 2017

2 Docs Talk About Pricing Transparency

2 Docs Talk About Medicare for All

2 Docs Talk About Drug Pricing

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Jan 23, 2017

The 21st Century Cures Act was passed by both bodies of Congress and signed into law by President Obama on December 7, 2016. The bill received overwhelming bipartisan support, with only a small number (of notable) exceptions.

On the surface, the law sounds like a triumph for healthcare and medical research. But a closer look at funding for the act brings its staying power into question. The only provisions of the law that don't require further action to maintain funding benefit one lucky group. 

Here's a hint: it's not patients. 

So today, 2 Docs Talk about what the 21st Century Cures Act accomplishes and what it doesn't accomplish. Buckle up. 

Resources:

Legislative history and text of 21st Century Cures Act

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Nov 14, 2016

November 8, 2016 has come and gone and no matter what box you checked you are probably a little surprised by the outcome. Donald Trump will be the 45th POTUS. 

This has the potential to shake things up in a lot of areas of American life, but we want to focus today on the healcare ramifications of a  Donald Trump presidency. What did he say he would do? Will he do it? And what will it look like if he does.

We refer to a couple of our previous podcasts in this show and they are worth a listen as you evaluate the plans Donald Trump is offering up:

Episode 10: What Does Planned Parenthood Actually Do?

Episode 6: Pricing Transparents in Medicine and Healthcare

Nov 7, 2016

The process of drug approval is long and expensive. To complicate matters, pharmaceutical companies, patients, an the FDA are all invested in the process, for different reasons - and they aren't always the same.

Today we discuss the story of how a new drug came to market and the unusual circumstances around its approval. 

Resources:

FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

CDC on Duchenne Muscular Dystrophy

Right to Try

Compassionate Use

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Oct 24, 2016

If you've paid any attention to the news over the past year or so, you've likely seen stories of greedy capitalists gouging the vulnerable by hiking up the prices of their life-saving drugs.

But are the prices hikes all that bad?

Yes. Yes, they are. And we talk about that to day on 2 Docs Talk.

Resources:

JAMA on Drug Pricing

Our episode on Hep C

Our episode on Alzheimers

Our episode on Pricing Transparency

Sep 19, 2016

If there is a hot button issue in politics these days, it's abortion. But abortion is the result of a long line of issues that are being inadequately addressed in this country. Today we take a look at contraception - what it is, how it works, its history and its future. 

We also offer a look at an innovative program that has the potential to help both pro-choice and pro-life groups happy. 

 

Resources:

Details on various types of birth control

The Choice Project

Use of LARCs in Colorado

Slang for using a condom (adult humor - you've been warned)

 

Be sure and subscribe in iTunes or Stitcher if you haven’t already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

Jul 25, 2016

In this episode, we dig into the terms being bandied about by politicians this year. Medicare for all, single-payer, socialized medicine. What do they all mean? Are they all the same or are there differences between these systems. 

And what would we do, today, to start making healthcare work a little better?

Resources:

Per Capita Health Spending by Country

Gallup Poll on Healthcare Satisfaction by Country

 

Jun 20, 2016

 

If you watch any tv at all, it's likely you've seen a drug ad. These ads generally show seemingly healthy people living normal lives, the message being the drug did this for them.

But are the drug ads telling the whole story? And should they even be advertising directly to consumers to begin with? We discuss this issue on today's episode.

 

Resources:

Nivolumab Research from New England Journal of Medicine

What the FDA has to say about drug ads

Be sure and subscribe in iTunes or Stitcher if you haven't already.  And you know we’d appreciate it so much if you would tell your friends about 2 Docs Talk!

Listen on iTunes

Listen on Stitcher

Now Available on Google Play Music!

May 23, 2016

In a world when concerns about healthcare costs, access to care, and medical complications create significant barriers to medical care, telemedicine has an obvious role to fill. 

But what are the potential downsides of a technology that is being adopted faster than we can track? Is it effective? Is it safe? Is it a door for the unscrupulous ot take advantage of the unsuspecting?

We discuss these and other issues of the growing field of telemedicine. 

Resources:

AMA policy on telemedicine

AAFP debate on telemedicine policy

AAP on telemedicine and the "medical home"

Hospital at Home

Use of telemedicine to prevent preterm labor

Mar 28, 2016

In this episode, we dig into the terms being bandied about by politicians this year. Medicare for all, single-payer, socialized medicine. What do they all mean? Are they all the same or are there differences between these systems. 

And what would we do, today, to start making healthcare work a little better?

Resources:

Per Capita Health Spending by Country

Gallup Poll on Healthcare Satisfaction by Country

Feb 15, 2016

Opioid abuse is at an ever increasing high in the U.S. with overdose being a significant cause of death. 

What role do physicians, pharmaceutical companies, and the drug users themselves play in this epidemic. We examine these questions and more in this episode on the opioid problem in the United States.

Resources:

Drug Overdose Deaths by State

Draft CDC Guidelines for Prescribing Opioids for Chronic Pain

Specific Populations and Prescription Drug Misuse and Abuse

1 2 Next »